Valuation : Kim Forest Enterprise Co., Ltd.

Market Cap 782M 24.54M 21.06M 19.77M 18.05M 34.07M 2.34B 34.24M 234M 90.66M 1.18B 92.13M 90.13M 3.91B P/E 2024
-7.91x
P/E 2025 -7.34x
Enterprise Value 1.04B 32.7M 28.07M 26.34M 24.06M 45.41M 3.12B 45.63M 312M 121M 1.57B 123M 120M 5.21B EV / Sales 2024
2.86x
EV / Sales 2025 2.43x
Free-Float
43.95%
Yield 2024 *
-
Yield 2025 -
1 day+0.77%
1 week+1.95%
Current month-1.87%
1 month-5.42%
3 months+11.02%
6 months-25.57%
Current year-25.99%
1 week 12.85
Extreme 12.85
13.25
1 month 11.75
Extreme 11.75
14.1
Current year 11.4
Extreme 11.4
18.5
1 year 11.4
Extreme 11.4
26.45
3 years 11.4
Extreme 11.4
48.1
5 years 11.4
Extreme 11.4
50.38
10 years 8.27
Extreme 8.27329
122.57
Manager TitleAgeSince
Chief Executive Officer - 2005-06-30
Director of Finance/CFO - 2013-12-01
Chief Tech/Sci/R&D Officer - 2016-10-31
Director TitleAgeSince
Chairman - 2014-09-21
Director/Board Member - 2004-07-27
Director/Board Member - 2016-06-28
Change 5-day change 1-year change 3-year change Capi.($)
+0.77%+1.95%-32.47%-67.17% 24.54M
+1.84%-0.67%-38.27%-40.27% 644M
+2.81%-8.80%+82.76% - 343M
-7.13%-2.58%-36.21%-9.46% 134M
-0.51%-1.01%-19.26%+24.68% 77.63M
Average -0.44%-0.79%-8.69%-23.06% 244.65M
Weighted average by Cap. +0.96%-1.35%-2.83%-30.60%

Financials

2024 2025
Net sales 502M 15.74M 13.51M 12.68M 11.58M 21.85M 1.5B 21.96M 150M 58.15M 757M 59.09M 57.81M 2.51B 549M 17.23M 14.79M 13.88M 12.68M 23.93M 1.64B 24.04M 164M 63.67M 829M 64.7M 63.3M 2.75B
Net income -160M -5.02M -4.31M -4.04M -3.69M -6.97M -479M -7M -47.83M -18.54M -241M -18.84M -18.43M -800M -146M -4.6M -3.94M -3.7M -3.38M -6.38M -438M -6.41M -43.81M -16.98M -221M -17.25M -16.88M -732M
Net Debt 147M 4.6M 3.95M 3.7M 3.38M 6.38M 438M 6.41M 43.83M 16.99M 221M 17.26M 16.89M 733M 260M 8.16M 7.01M 6.58M 6.01M 11.33M 779M 11.39M 77.82M 30.16M 393M 30.65M 29.98M 1.3B
Logo Kim Forest Enterprise Co., Ltd.
KIM FOREST ENTERPRISE CO., LTD. is a Taiwan-based company mainly engaged in sale of biomedical products and provision of genetic testing and analysis services. The Company operates through two segments. The Biomedical Experiment Products segment is engaged in provision of laboratory equipment, reagents, supplies and equipment maintenance services. Main products include filter type microplate spectrophotometer, polymerase chain reaction (PCR) molecular biology experiment related equipment and reagents, equipment and reagents for separating cell, protein and nucleic acids, rapid DNA detection reagent and others. The Biotechnology and Genetic Testing segment is engaged in provision of whole genome sequencing (WGS) and whole exome sequencing(WES) tumor analysis services, RNA sequencing analysis, and new drug development system and check services.
Employees
-
Date Price Change
26-08-26 NT$12.95 -1.15%
26-08-25 NT$13.10 +0.77%
26-08-24 NT$13.00 -0.38%
26-08-21 NT$13.05 +1.16%
26-08-20 NT$12.90 +1.57%
  1. Stock Market
  2. Stocks
  3. 6645 Stock